Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D

PHASE4CompletedINTERVENTIONAL
Enrollment

272

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Chronic Kidney DiseaseSecondary HyperparathyroidismHemodialysis
Interventions
DRUG

Paricalcitol

Paricalcitol dosed per label by region (participants were to receive cinacalcet if they developed hypercalcemia)

DRUG

Cinacalcet

On-label oral cinacalcet by region with low dose vitamin D receptor activator (VDRA) (either doxercalciferol at US sites or alfacalcidol at non-US sites)

Trial Locations (83)

2100

Site Reference ID/Investigator# 23105, Copenhagen

7000

Site Reference ID/Investigator# 23909, Fredericia

7500

Site Reference ID/Investigator# 22462, Holstebro

9000

Site Reference ID/Investigator# 22363, Aalborg

11355

Site Reference ID/Investigator# 22505, Flushing

11528

Site Reference ID/Investigator# 22362, Athens

14004

Site Reference ID/Investigator# 21364, Córdoba

16132

Site Reference ID/Investigator# 21746, Genova

17604

Site Reference ID/Investigator# 22796, Lancaster

19106

Site Reference ID/Investigator# 22770, Philadelphia

20122

Site Reference ID/Investigator# 22314, Milan

24128

Site Reference ID/Investigator# 22312, Bergamo

24701

Site Reference ID/Investigator# 22776, Bluefield

27100

Site Reference ID/Investigator# 21367, Pavia

28040

Site Reference ID/Investigator# 38343, Madrid

28041

Site Reference ID/Investigator# 21362, Madrid

29115

Site Reference ID/Investigator# 21147, Orangeburg

29801

Site Reference ID/Investigator# 22772, Aiken

31008

Site Reference ID/Investigator# 22367, Pamplona

32806

Site Reference ID/Investigator# 22722, Orlando

33071

Site Reference ID/Investigator# 21370, Coral Springs

33173

Site Reference ID/Investigator# 22788, Miami

33313

Site Reference ID/Investigator# 21146, Lauderdale Lakes

Site Reference ID/Investigator# 26743, Lauderdale Lakes

33614

Site Reference ID/Investigator# 23147, Tampa

34667

Site Reference ID/Investigator# 25902, Hudson

38400

Site Reference ID/Investigator# 38462, Puerto de la Cruz

40113

Site Reference ID/Investigator# 21624, Ústí nad Labem

40210

Site Reference ID/Investigator# 35903, Düsseldorf

41007

Site Reference ID/Investigator# 21365, Seville

43606

Site Reference ID/Investigator# 22759, Toledo

48202

Site Reference ID/Investigator# 21369, Detroit

48236

Site Reference ID/Investigator# 22786, Detroit

51415

Site Reference ID/Investigator# 22310, Jilemnice

54636

Site Reference ID/Investigator# 22322, Thessaloniki

54642

Site Reference ID/Investigator# 22463, Thessaloniki

55100

Site Reference ID/Investigator# 39180, Lucca

56403

Site Reference ID/Investigator# 22323, Thessaloniki

58185

Site Reference ID/Investigator# 23913, Linköping

58515

Site Reference ID/Investigator# 21368, Lüdenscheid

60590

Site Reference ID/Investigator# 21742, Frankfurt

61100

Site Reference ID/Investigator# 21745, Pesaro

63110

Site Reference ID/Investigator# 21144, St Louis

Site Reference ID/Investigator# 21443, St Louis

64295

Site Reference ID/Investigator# 33268, Darmstadt

65691

Site Reference ID/Investigator# 22311, Brno

68131

Site Reference ID/Investigator# 21145, Omaha

74076

Site Reference ID/Investigator# 21744, Heilbronn

77030

Site Reference ID/Investigator# 22982, Houston

77099

Site Reference ID/Investigator# 21143, Houston

78215

Site Reference ID/Investigator# 22506, San Antonio

80002

Site Reference ID/Investigator# 23688, Arvada

83642

Site Reference ID/Investigator# 22778, Meridian

85284

Site Reference ID/Investigator# 22781, Tempe

90033

Site Reference ID/Investigator# 21142, Los Angeles

90048

Site Reference ID/Investigator# 22762, Los Angeles

91910

Site Reference ID/Investigator# 24342, Chula Vista

92123

Site Reference ID/Investigator# 21442, San Diego

92505

Site Reference ID/Investigator# 22758, Riverside

96450

Site Reference ID/Investigator# 21748, Coburg

123182

Site Reference ID/Investigator# 24643, Moscow

125284

Site Reference ID/Investigator# 24642, Moscow

546 36

Site Reference ID/Investigator# 38970, Thessaloniki

570 01

Site Reference ID/Investigator# 39262, Thessaloniki

1815 JD

Site Reference ID/Investigator# 21842, Alkmaar

2625 AD

Site Reference ID/Investigator# 22309, Delft

3317 NM

Site Reference ID/Investigator# 21843, Dordrecht

7800-309

Site Reference ID/Investigator# 38903, Beja

8005- 546

Site Reference ID/Investigator# 38531, Faro

1750-130

Site Reference ID/Investigator# 22464, Lisbon

2600-076

Site Reference ID/Investigator# 23910, Vila Franca de Xira

08025

Site Reference ID/Investigator# 21361, Barcelona

08097

Site Reference ID/Investigator# 22366, L'Hospitalet, Barcelona

07014

Site Reference ID/Investigator# 21363, Palma de Mallorca

182 88

Site Reference ID/Investigator# 23782, Stockholm

751 85

Site Reference ID/Investigator# 22364, Uppsala

B18 7QH

Site Reference ID/Investigator# 23912, Birmingham

CV2 2DX

Site Reference ID/Investigator# 21747, Coventry

NW3 2PF

Site Reference ID/Investigator# 23102, London

SE1 9RT

Site Reference ID/Investigator# 23104, London

M6 8HD

Site Reference ID/Investigator# 23103, Manchester

BT79 0AP

Site Reference ID/Investigator# 41982, Omagh, Northern Ireland

S5 7AU

Site Reference ID/Investigator# 40222, Sheffield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY

NCT00977080 - Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D | Biotech Hunter | Biotech Hunter